Results 371 to 380 of about 191,621 (404)

Trends in kinase drug discovery: targets, indications and inhibitor design

Nature Reviews Drug Discovery, 2021
Misty M Attwood, Stefan Knapp
exaly  

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

Nature Medicine, 2022
Adriaan A Voors, Christiane Angermann Angermann, John R Teerlink   +2 more
exaly  

PROTON PUMP INHIBITORS IN INFANTS

Journal of Pediatric Gastroenterology and Nutrition, 2005
Thomas P. Iarocci, Hiangkiat Tan, Joseph Singer, Barron John, Edith Pilzer, Dinesh Patel, Alan Bakst   +6 more
openaire   +1 more source

Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use

Digestion, 2018
Y. Naito, Kaori Kashiwagi, T. Takagi, A. Andoh, R. Inoue   +4 more
semanticscholar   +1 more source

The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial

Nature Medicine, 2021
Barry A Borlaug, Dalane W Kitzman, Sanjiv J Shah   +2 more
exaly  

The Newest Proton Pump Inhibitor

Gastroenterology Nursing, 1995
openaire   +2 more sources

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Risk of ovarian function recovery should be considered when switching from treatment with adjuvant tamoxifen to aromatase inhibitor therapy in women with chemotherapy-induced amenorrhea

Ca-A Cancer Journal for Clinicians, 2018
Clement Chung
exaly  

An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

Nature, 2020
Ugur Sahin, Petra Oehm, Mathias Vormehr
exaly  

Oral microbiome alterations of healthy volunteers with proton pump inhibitor

Journal of Gastroenterology and Hepatology, 2018
Tsuyoshi Mishiro, K. Oka, Y. Kuroki, Motomichi Takahashi, Kasumi Tatsumi, Tsukasa Saitoh, Hiroshi Tobita, N. Ishimura, Shuichi Sato, S. Ishihara, J. Sekine, K. Wada, Y. Kinoshita   +12 more
semanticscholar   +1 more source